Crossref
journal-article
Elsevier BV
Neuron (78)
References
37
Referenced
482
10.1016/S0896-6273(00)80886-7
/ Neuron / Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system by Abeliovich (2000)10.1126/science.1067389
/ Science / Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease by Auluck (2002){'key': '10.1016/S0896-6273(03)00024-2_BIB3', 'first-page': '879', 'article-title': "Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies", 'volume': '152', 'author': 'Baba', 'year': '1998', 'journal-title': 'Am. J. Pathol.'}
/ Am. J. Pathol. / Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies by Baba (1998){'key': '10.1016/S0896-6273(03)00024-2_BIB4', 'first-page': 'E642', 'article-title': 'Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36', 'volume': '276', 'author': 'Bonen', 'year': '1999', 'journal-title': 'Am. J. Physiol.'}
/ Am. J. Physiol. / Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36 by Bonen (1999)10.1016/0003-2697(76)90527-3
/ Analyt. Biochem. / A rapid and sensitive method for the quantitaion of micrograms quantities of protein utilizing the principle of protein-dye binding by Bradford (1976)10.1074/jbc.M108414200
/ J. Biol. Chem. / Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein by Cole (2002)10.1523/JNEUROSCI.12-09-03392.1992
/ J. Neurosci. / A novel N18TG2 X mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin by Crawford (1992)10.1074/jbc.273.16.9443
/ J. Biol. Chem. / Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes by Davidson (1998)10.1001/archneur.1969.00480180071006
/ Arch. Neurol. / Sphingomyelin in Lewy inclusion bodies in Parkinson's disease by den Hartog Jager (1969)10.1016/0003-9861(69)90336-1
/ Arch. Biochem. Biophys. / Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin by Eylar (1969)10.1038/35006074
/ Nature / A drosophila model of Parkinson's disease by Feany (2000)10.1006/exnr.2000.7527
/ Exp. Neurol. / In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies by Gai (2000)10.1016/0896-6273(95)90040-3
/ Neuron / Characterization of a novel protein regulated during the critical period for song learning in the zebra finch by George (1995)10.1016/S0896-6273(02)00682-7
/ Neuron / Neuronal alpha-Synucleinopathy with severe movement disorder in mice expressing A53T human alpha-Synuclein by Giasson (2002)10.1016/S0952-3278(99)80002-7
/ Prostaglandins Leukot. Essent. Fatty Acids / Transport of fatty acids across membranes by the diffusion mechanism by Hamilton (1999)10.2337/diabetes.48.12.2255
/ Diabetes / How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? by Hamilton (1999)10.1016/S0896-6273(01)00462-7
/ Neuron / beta-Synuclein inhibits alpha-synuclein aggregation by Hashimoto (2001)10.1016/S0002-9440(10)63072-6
/ Am. J. Pathol. / Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model by Kahle (2001)10.1038/ng0298-106
/ Nat. Genet. / Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease by Kruger (1998)10.1073/pnas.132197599
/ Proc. Natl. Acad. Sci. USA / Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice by Lee (2002)10.1126/science.287.5456.1265
/ Science / Dopaminergic loss and inclusion body formation in a-Synuclein mice by Masliah (2000)10.1074/jbc.275.12.8812
/ J. Biol. Chem. / Membrane association and protein conformation of a-Synuclein in intact neurons by McLean (2000)- Nelson, D.L., and Cox, M.M. (2000). Lehninger Principles of Biochemistry, 3rd Edition, chapter 17 (New York: Worth Publishers).
10.1016/0003-9861(70)90361-9
/ Arch. Biochem. Biophys. / Allergic encephalomyelitis by Oshiro (1970)10.1074/jbc.M004851200
/ J. Biol. Chem. / Interaction of human a-Synuclein and Parkinson's disease variants with phospholipids by Perrin (2000)10.1074/jbc.M105022200
/ J. Biol. Chem. / Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins by Perrin (2001)10.1126/science.276.5321.2045
/ Science / Mutation in the alpha-synuclein gene identified in families with Parkinson's disease by Polymeropoulos (1997)10.1016/S0021-9258(18)35866-6
/ J. Biol. Chem. / A fluorescently labeled intestinal fatty acid binding protein. Interactions with fatty acids and its use in monitoring free fatty acids by Richieri (1992)10.1016/0092-8674(94)90252-6
/ Cell / Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein by Schaffer (1994)10.1073/pnas.171300598
/ Proc. Natl. Acad. Sci. USA / alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins by Sharon (2001)10.1016/S0014-5793(00)01563-5
/ FEBS Lett. / Chaperone-like activity of synucleins by Souza (2000)10.1038/42166
/ Nature / aSynuclein in lewy bodies by Spillantini (1997)10.1073/pnas.95.11.6469
/ Proc. Natl. Acad. Sci. USA / a-Synuclein in filamentous inclusions of lewy bodies from parkinson's disease and dementia with lewy bodies by Spillantini (1998)10.1038/416535a
/ Nature / Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo by Walsh (2002)10.1038/nm0602-600
/ Nat. Med. / Dopamine-dependent neurotoxicity of alpha-synuclein by Xu (2002)10.1016/S0304-3940(97)00938-5
/ Neurosci. Lett. / Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex by Zimmer (1998)10.1016/S0304-3940(00)00950-2
/ Neurosci. Lett. / Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex by Zimmer (2000)
Dates
Type | When |
---|---|
Created | 21 years, 4 months ago (April 21, 2004, 3:12 a.m.) |
Deposited | 1 year, 4 months ago (April 22, 2024, 12:57 p.m.) |
Indexed | 1 hour, 11 minutes ago (Sept. 2, 2025, 7:10 p.m.) |
Issued | 22 years, 7 months ago (Feb. 1, 2003) |
Published | 22 years, 7 months ago (Feb. 1, 2003) |
Published Print | 22 years, 7 months ago (Feb. 1, 2003) |
Funders
1
National Institutes of Health
10.13039/100000002
Region: Americas
gov (National government)
Labels
3
- Institutos Nacionales de la Salud
- US National Institutes of Health
- NIH
Awards
1
- NS 38375
@article{Sharon_2003, title={The Formation of Highly Soluble Oligomers of α-Synuclein Is Regulated by Fatty Acids and Enhanced in Parkinson’s Disease}, volume={37}, ISSN={0896-6273}, url={http://dx.doi.org/10.1016/s0896-6273(03)00024-2}, DOI={10.1016/s0896-6273(03)00024-2}, number={4}, journal={Neuron}, publisher={Elsevier BV}, author={Sharon, Ronit and Bar-Joseph, Ifat and Frosch, Matthew P and Walsh, Dominic M and Hamilton, James A and Selkoe, Dennis J}, year={2003}, month=feb, pages={583–595} }